Skip to main contentSkip to navigationSkip to search

News and Media

Curasight is committed to improving both diagnosis and treatment options for patients with certain types of cancer.

Our innovative theranostic platform, uPAR, allows us to more accurately characterize the type and stage of tumors using intelligent cancer imaging (uTRACE®) and with that knowledge, develop a more targeted, gentle and efficient approach to treatment (uTREAT®).

See our latest news releases & events, sign up to receive alerts and get answers to our most frequently asked questions.